Amphastar Pharmaceuticals (AMPH) News Today $40.85 +0.01 (+0.02%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells $310,940.00 in StockDecember 17 at 4:35 AM | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) EVP Rong Zhou sold 7,000 shares of the business's stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $44.42, for a total transaction of $310,940.00. Following the sale, the executive vice president now directly owns 118,469 shares in the company, valued at approximately $5,262,392.98. This represents a 5.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.December 16 at 7:44 PM | marketbeat.comWorld Investment Advisors LLC Invests $1.61 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)World Investment Advisors LLC bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 33,249 shares of the company's stocDecember 15 at 5:11 AM | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4% - Here's WhyAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 5.4% - Time to Sell?December 13, 2024 | marketbeat.comXTX Topco Ltd Invests $674,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)XTX Topco Ltd purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 13,891 shares of the company's stock, valued at approximatelyDecember 13, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $437,700.00 in StockDecember 12, 2024 | insidertrades.comCentiva Capital LP Sells 17,110 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Centiva Capital LP lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 72.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,465 shares of the company's stock after selling 17,110 shaDecember 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Sells 197,019 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Point72 Asset Management L.P. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 83.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 38,817 shares of the company's stock after selling 197,019 shares during theDecember 10, 2024 | marketbeat.comTaika Capital LP Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Taika Capital LP bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 36,775 shares of the company's stock, valued atDecember 6, 2024 | marketbeat.comHotchkis & Wiley Capital Management LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Hotchkis & Wiley Capital Management LLC purchased a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 222,620 shares of the company's stock, valDecember 5, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 59.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,466 shares of the companDecember 4, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Dynamic Technology Lab Private LtdDynamic Technology Lab Private Ltd lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 70.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,682 shares of the company's stock after sellinDecember 3, 2024 | marketbeat.comGlenmede Trust Co. NA Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Glenmede Trust Co. NA lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 145.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,884 shares of the company'December 2, 2024 | marketbeat.comWhy Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?November 30, 2024 | msn.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare ConferenceNovember 27, 2024 | finanznachrichten.deAlgert Global LLC Takes $3.22 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Algert Global LLC bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 66,285 shares of the company's stock, valNovember 26, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Holdings Lessened by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. cut its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 19.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 83,673 shares of the company's stock after selling 20,448 shares during thNovember 24, 2024 | marketbeat.com18,968 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC bought a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 18,968 shares of the company's stock, valued at approximateNovember 24, 2024 | marketbeat.comAmphastar initiated with an Equal Weight at Wells FargoNovember 23, 2024 | markets.businessinsider.comWells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight RecommendationNovember 23, 2024 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Wells Fargo & CompanyWells Fargo & Company began coverage on Amphastar Pharmaceuticals in a research note on Friday. They issued an "equal weight" rating and a $55.00 target price for the company.November 22, 2024 | marketbeat.comVictory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Victory Capital Management Inc. increased its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 10.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 218,531 shares of the company's stockNovember 21, 2024 | marketbeat.comPrincipal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Principal Financial Group Inc. decreased its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 202,017 shares of the company's stock after selling 16,155 shares during thNovember 19, 2024 | marketbeat.comLos Angeles Capital Management LLC Takes $785,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Los Angeles Capital Management LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 16,169 shares of the coNovember 16, 2024 | marketbeat.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 5,000 Shares of StockNovember 14, 2024 | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of StockNovember 9, 2024 | insidertrades.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 7,426 SharesNovember 9, 2024 | insidertrades.comWilliam J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) CFO William J. Peters sold 7,426 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.05, for a total transaction of $386,523.30. Following the transaction, the chief financial officer now owns 94,103 shares in the company, valued at approximately $4,898,061.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.November 8, 2024 | marketbeat.comNeedham Remains a Hold on Amphastar Pharmaceuticals (AMPH)November 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Reports Strong Q3 2024 ResultsNovember 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | insidermonkey.comAmphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?November 7, 2024 | marketbeat.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...November 7, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to ExpectNovember 5, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.comStockNews.com cut Amphastar Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Friday.November 1, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Trims Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Allspring Global Investments Holdings LLC trimmed its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 40.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,263 shares of the company's stocNovember 1, 2024 | marketbeat.comInternational Assets Investment Management LLC Invests $11.07 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)International Assets Investment Management LLC bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 22,809 shares of thOctober 31, 2024 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on WednesdayAmphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports.October 30, 2024 | marketbeat.comEyePoint Pharmaceuticals’ Positive Clinical Data Boosts Buy Rating Amid Promising Eye Disease TherapiesOctober 29, 2024 | markets.businessinsider.comAssenagon Asset Management S.A. Reduces Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Assenagon Asset Management S.A. lessened its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 11.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 167,355 shares of the company's stock after sellingOctober 29, 2024 | marketbeat.comBoston Trust Walden Corp Acquires Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Boston Trust Walden Corp bought a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 539,639 shares of the company's stock, valOctober 27, 2024 | marketbeat.comAmphastar: Objectively Undervalued But For Good Reason (Rating Downgrade)October 25, 2024 | seekingalpha.comAnalysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Collegium Pharmaceutical (COLL) and Korro Bio (KRRO)October 24, 2024 | markets.businessinsider.comMoody Aldrich Partners LLC Purchases 44,606 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Moody Aldrich Partners LLC increased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 80.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,340 shares of the company's stock after buyinOctober 24, 2024 | marketbeat.comAmphastar Pharm Shows Rising Relative Strength; Still Shy Of Key BenchmarkOctober 18, 2024 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by StockNews.com to "Buy"StockNews.com raised Amphastar Pharmaceuticals from a "hold" rating to a "buy" rating in a report on Friday.October 18, 2024 | marketbeat.comIBD Rating Upgrades: Amphastar Pharm Flashes Improved Relative Price StrengthOctober 16, 2024 | msn.comAmphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?October 16, 2024 | finance.yahoo.com Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address How to piss off your liberal friends… and profit from it (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies. To get the full details on the fake “energy crisis” of America, watch this now AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼0.790.71▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼94▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RVMD News Today LNTH News Today LEGN News Today NUVL News Today BPMC News Today ELAN News Today CYTK News Today TGTX News Today VKTX News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
